| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. (HOWL) has 4 insiders with recent SEC Form 4 filings, including 7 buys and 14 sells. HOWL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.78M | $1.68M | - | |
| 10% | 4.78M | $1.68M | - | |
| Dir | 377.2K | $132.4K | -173,515 | |
| 10% | 361.2K | $126.8K | -678,226 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | Evnin Luke55 | Director | Sell | 177,145 | $1.62 | $286,497.06 | -1.4% | -57.0% | - | |
| Oct 29, 2025 | Gadicke Ansbert85 | 10% Owner | Sell | 276,017 | $1.62 | $446,403.00 | -1.4% | -57.0% | - | |
| Oct 29, 2025 | Mpm Bioventures 2014, L.P.67 | 10% Owner | Sell | 276,017 | $1.62 | $446,403.00 | -1.4% | -57.0% | - | |
| May 14, 2025 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 536,426 | $0.91 | $487,187.92 | +3.0% | +21.2% | -45.2% | |
| Mar 27, 2025 | Mpm Bioventures 2014, L.P.67 | 10% Owner | Sell | 1,963 | $1.05 | $2,061.15 | - | +11.7% | -27.0% | |
| Mar 27, 2025 | Gadicke Ansbert85 | 10% Owner | Sell | 4,386 | $1.05 | $4,605.30 | - | +11.7% | -27.0% | |
| Mar 27, 2025 | Evnin Luke55 | Director, 10% Owner | Sell | 2,425 | $1.05 | $2,546.25 | - | +11.7% | -27.0% | |
| Jan 6, 2023 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 1,853,000 | $2.21 | $4,095,130.00 | +48.2% | +11.1% | +138.2% | |
| Dec 15, 2021 | Leonard Reid | Chief Operating Officer | Sell | 3,000 | $13.41 | $40,241.62 | -1.2% | -67.0% | -85.9% | |
| Jun 16, 2021 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 323,298 | $12.77 | $4,129,397.80 | +2.6% | +25.5% | -69.5% |